The FDA just made a move that changes everything for my patients. For nearly two years, some of the most clinically promising peptides in longevity and autoimmune medicine were locked away DIHEXA Research Capsules Peptide Tech FDA to Review 12 Peptides for Clinical Oversight Ramesh Kumar MD posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York